Understanding adverse drug reactions in older adults through drug-drug interactions

European Journal of Internal Medicine

Volumn 25, Issue 9, 2014, Pages 843-846

  Marengoni, A ^a   Pasina, L ^b   Concoreggi, C ^c   Martini, G ^c   Brognoli, F ^c   Nobili, A ^b   Onder, G ^d   Bettoni, D ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SPEDALI CIVILI   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Adverse drug reaction; Drug drug interaction; Elderly

Indexed keywords

ACENOCOUMAROL; ALLOPURINOL; AMIODARONE; ANTICOAGULANT AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; WARFARIN; HEMATOLOGIC AGENT;

ADVERSE DRUG REACTION; AGED; ALLERGIC REACTION; ARTICLE; BLEEDING; DRUG DRUG INTERACTION; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; HUMAN; INTERNATIONAL NORMALIZED RATIO; ITALY; MAJOR CLINICAL STUDY; PRESCRIPTION; PREVALENCE; AGE; CHEMICALLY INDUCED; DRUG HYPERSENSITIVITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEMORRHAGE; MALE;

ACENOCOUMAROL; AGE FACTORS; AGED; ALLOPURINOL; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEMATOLOGIC AGENTS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ITALY; MALE; PREVALENCE; PROTON PUMP INHIBITORS; WARFARIN;

EID: 84912115494     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.10.001     Document Type: Article

References (22)

1. Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999;14(2):141-52.
2. Onder G, van der Cammen TJ, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing 2013;42(3):284-91.
3. Cerreta F, Eichler HG, Rasi G. Drug policy for an aging population-the European Medicines Agency's geriatric medicines strategy. N Engl J Med 2012;367(21):1972-4.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-97.
5. Garattini S, Nobili A. Interazioni tra farmaci: una valutazione della loro rilevanza clinica. Pavia: Selecta Medica Eds.; 2001.
6. Ghibelli S, Marengoni A, Djade CD, Nobili A, Tettamanti M, Franchi C. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)). Drugs Aging 2013;30(10):821-8.
7. Vonbach P, Dubied A, Krahenbuhl S, Beer JH, et al. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med 2008;19:413-20.
8. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12.
9. Pasina L, Nobili A, Tettamanti M, Salerno F, Corrao S, Marengoni A, et al. REPOSI investigators. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med 2011;22(2):205-10.
10. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology 2005;44(8):1038-42.
11. Luk AJ, Levin GP, Moore EE, et al. Allopurinol and mortality in hyperuricaemic patients. Rheumatology 2009;48(7):804-6.
12. Thanassoulis G, Brophy JM, Richard H, et al. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010;170(15):1358-64.
13. Gois PH, Souza ER. Pharmacotherapy for hyperuricemia in hypertensive patients. Cochrane Database Syst Rev Jan 31 2013;1:CD008652.
14. Calogiuri G, Nettis E, Di Leo E, Foti C, Ferrannini A, Butani L. Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules. Inflamm Allergy Drug Targets 2013;12(1):19-28.
15. Tleyjeh IM, Bin Abdulhak AA, Riaz M, Alasmari FA, Garbati MA, AlGhamdi M, et al. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One 2012;7(12):e50836.
16. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2007;16:641-51.
17. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011;9(6):364-77.
18. Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009;34(4):377-86.
19. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329(7456):15-9.
20. Espinosa-Bosch M, Santos-Ramos B, Gil-Navarro MV, Santos-Rubio MD, Marín-Gil R, Villacorta-Linaza P. Prevalence of drug interactions in hospital healthcare. Int J Clin Pharmacol 2012;34(6):807-17.
21. Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, Guidoni CM, de Lyra Júnior DP, Pilger D, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol 2012;68(12):1667-76.
22. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012;29(6):453-62.